GlassScriptPhysician profile
Jeffrey Todd Starkey
NPI 1780661942
$1,513.77
in general payments reported to CMS, 2019-2025
19 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $103 · 2021: $160 · 2022: $467 · 2023: $163 · 2024: $270 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.17 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $254.84 | 2022-2024 | Tyrvaya |
| Alcon Vision LLC | $199.54 | 2019-2025 | Precision7, Hydrus Microstent, Lensx |
| Sun Pharmaceutical Industries INC. | $135.44 | 2019-2025 | |
| Bausch & Lomb Americas INC. | $132.14 | 2023-2024 | Miebo, Xiidra |
| New World Medical,INC. | $124.86 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $119.70 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $108.46 | 2020-2022 | |
| Glaukos Corporation | $84.11 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Abbvie INC. | $58.13 | 2022-2024 | |
| Amgen INC. | $55.74 | 2024-2025 | Tepezza |
| Biotissue Holdings INC. | $49.30 | 2021-2023 | |
| Kala Pharmaceuticals, INC. | $44.87 | 2019-2022 | |
| Shire North American Group INC | $39.44 | 2019 | |
| Tearlab Corp | $29.82 | 2022-2023 | Tearlab Osmolarity System |
| Thea Pharma INC. | $18.86 | 2025 | Iyuzeh |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $16.52 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $15.56 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.29 | 2019 | |
| Allergan, INC. | $12.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Starkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.